top of page

Innovative Bioresearch Aims To Disrupt Pharma with INNBC - CEO interview on

Great and inspiring interview with Innovative Bioresearch CEO Jonathan Fior, on how INNBC, the first and only real biotech token on the market with actual scientific publications, aims to disrupt the pharmaceutical industry introducing INNBC as a decentralized tool to fund scientific research bypassing the traditional economical conflict of interests and developing cheaper therapies for diseases such as HIV, cancer, and recently COVID19.

125 views2 comments
bottom of page